What Advances Are Being Made in Tissue Compatibility?
Advances in immunosuppressive therapies, tissue engineering, and genetic engineering are improving tissue compatibility. Techniques such as CRISPR can potentially edit donor cells to reduce immunogenicity. Moreover, the development of tolerogenic protocols aims to induce long-term immune tolerance to grafts without the need for lifelong immunosuppression.
